For KHIDI (Korea Health Industry Development Institute), a government organization established by the Korea Ministry of Health and Welfare that is responsible for promoting growth of the Korean healthcare industry, CR conducted a market analysis on five specialist healthcare services (oncology, orthopedics, long term care, rehabilitation and sports medicine) for their potential to operate services in the UAE along with possible structures. These services were amongst many that were identified in a previously completed market entry strategy study. The study identified market opportunity and size as well as price points.
Undertook a feasibility study for setting up a paediatric rehabilitation center in Abu Dhabi for United Eastern Medical Services, a leading healthcare operator in the UAE jointly with Seoul Rehabilitation Hospital from Korea. Scope included supply and demand derivation, sizing, facility and equipment planning, costing, financial modelling and developing the value proposition for investment decision-making.
For Mubadala Development International, a major sovereign fund, CR was lead advisor their investment in a joint venture with Imperial College, London to set up the Imperial College Diabetes Centre in Abu Dhabi. CR was responsible for technical, commercial and financial analysis and due diligence on the deal as well as advising on partnership arrangements.
For a client developed an outline strategy for establishing a stem cell therapy center in the UAE which involved examining regulatory issues and partnership arrangements.
For the Ministry of Health of Saudi Arabia, worked as subject matter expert with a team from financial advisor KPMG and legal advisor Jones Day in relation to appointing a healthcare operator to re-operationalize a 600-bed hospital in the Eastern Province.
For SAM Hospital, a leading cancer treatment center and maternity hospital in South Korea, advised on market entry potential into Fujairah in the UAE in the specific service areas of cancer, maternity and IVF.